52 Week Range
As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Yestar Healthcare Holdings Proposed New Offshore Debt Restructuring And New RSA
Yestar Healthcare Posts HY Profit Attributable RMB 111.9 MLN
Yestar Healthcare Sees Consolidated Net Profit Of Not Less Than Rmb115 Million For Six Months
Yestar Healthcare Holdings Company Limited., formerly Yestar International Holdings Company Limited is an investment holding company principally engaged in the manufacture and sale of medical imaging products. The Company operates its business through two segments. The Imaging Printing Products segment is engaged in the manufacture and sale of color photographic paper, industrial Non Destructive Testing (NDT) x-ray films and the trading of imaging equipment. The Medical Products and Equipment segment is engaged in the manufacture and sale of medical dry films, medical wet films and dental films and the sale of medical equipment and reagents.
Room 805, Block 2
No. 58 Shen Jian Dong Lu, Min Hang Dist.
Min Hang Dist.
Chairman of the Board, Chief Executive Officer, Executive Director
Chief Financial Officer, Executive Director
Tsz Hin Ngai
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
* YESTAR HEALTHCARE HOLDINGS CO LTD - ITS HIGH QUALITY STANDARD DISPOSABLE MEDICAL MASK PRODUCT COMMENCED PRODUCTION IN MARCH 2020
* DEAL FOR GUANGZHOU'S ENTIRE TISSUE DIAGNOSTIC ARM, VALUED AT RMB 77 MILLION, IN EXCHANGE AS CONSIDERATION
* FY PROFIT ATTRIBUTABLE DECREASED BY ABOUT 19.5% TO ABOUT RMB202.7 MILLION
* 84 DISINFECTANT STARTED PRODUCTION AFTER APPROVAL BY PEOPLE'S GOVERNMENT OF GUANGXI ZHUANG AUTONOMOUS REGION Source text for Eikon: Further company coverage:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.